Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-08 Sale |
2022-09-12 4:24 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
19,210 | $32.5 | $624,325 | 365,009 (Direct) |
View |
| 2022-08-22 Sale |
2022-08-24 4:05 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
9,605 | $32.5 | $312,163 | 384,219 (Direct) |
View |
| 2022-08-15 Sale |
2022-08-17 4:15 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
9,606 | $34.12 | $327,757 | 393,824 (Direct) |
View |
| 2022-08-05 Sale |
2022-08-09 8:59 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
57,635 | $34.54 | $1,990,804 | 826,071 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Option Award |
2025-02-04 5:30 pm |
N/A 2035-02-03 |
Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer |
428,000 | $0 | 428,000 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-13 6:13 pm |
2025-06-12 2034-06-12 |
Pacira BioSciences Inc. | PCRX | Ceesay Abraham Director |
17,409 | $0 | 17,409 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 7:39 pm |
N/A 2034-06-05 |
Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer |
530,647 | $0 | 530,647 (Direct) |
View |
Ownership |
2024-06-06 6:49 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer |
0 | $0 | 1,307,854 (Direct) |
View |
| 2023-10-06 Option Award |
2023-10-11 4:46 pm |
N/A 2033-10-06 |
Pacira BioSciences Inc. | PCRX | Ceesay Abraham Director |
30,967 | $0 | 30,967 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-08 8:29 pm |
N/A 2033-02-06 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
143,528 | $0 | 143,528 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-12 4:24 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
19,210 | $13.17 | 365,009 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-12 4:24 pm |
N/A 2031-06-01 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
19,210 | $0 | 365,009 (Direct) |
View |
| 2022-08-22 Exercise |
2022-08-24 4:05 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
9,605 | $13.17 | 384,219 (Direct) |
View |
| 2022-08-22 Exercise |
2022-08-24 4:05 pm |
N/A 2031-06-01 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
9,605 | $0 | 384,219 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-17 4:15 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
9,606 | $13.17 | 393,824 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-17 4:15 pm |
N/A 2031-06-01 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
9,606 | $0 | 393,824 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 8:59 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
57,635 | $13.17 | 826,071 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 8:59 pm |
N/A 2031-06-01 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
57,635 | $0 | 826,071 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:46 pm |
N/A 2032-02-09 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
120,310 | $0 | 120,310 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 4:24 pm |
N/A 2031-06-01 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
461,065 | $0 | 461,065 (Direct) |
View |